ProfileGDS4177 / 231010_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 34% 15% 13% 21% 26% 24% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated17.5334
GSM603099KU-812 non-treated9.2915
GSM603098KCL-22 Imatinib-treated8.5213
GSM603097KCL-22 non-treated11.0221
GSM603102JURL-MK1 Imatinib-treated13.3326
GSM603101JURL-MK1 non-treated12.3424